Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-021382

Options or other derivatives

  • Sr. VP & General Counsel acquired 83,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gardiner Nathaniel S. · Sr. VP & General Counsel

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-22 Grant or award : show line 1 in the form Stock Option (right to buy) +83,000 83,000 D
Loading xslF345X05/form4.xml…